Design and synthesis of HCV agents with sequential triple inhibitory potentials
…, MB Fawzi, M Flint, F Kong, J Szeliga, R Tsao…
Index: Zhu, Tianmin; Fawzi, Mahdi B.; Flint, Michael; Kong, Fangming; Szeliga, Jan; Tsao, Russ; Howe, Anita Y.M.; Pan, Weitao Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 17 p. 5212 - 5216
Full Text: HTML
Citation Number: 8
Abstract
Hepatitis C is a serious world wide health problem caused by RNA virus—hepatitis C virus infection that infects about 170 million people. 1 Failed treatment or under treatment, which is not uncommon due to its asymptotic nature, leads to chronic hepatitis C. 1 Chronic hepatitis C, defined as hepatitis C virus persisting for more than six months, can cause chronic liver inflammation that can develop into cirrhosis and cancer, and is the most common reason for liver transplantation. While ...
Related Articles:
[Liu, Wei-Yong; Li, Hai-Ying; Zhao, Bao-Xiang; Shin, Dong-Soo; Lian, Song; Miao, Jun-Ying Carbohydrate Research, 2009 , vol. 344, # 11 p. 1270 - 1275]
Lactobacillus reuteri 2′-deoxyribosyltransferase, a novel biocatalyst for tailoring of nucleosides
[Trelles; Fernandez; Lewkowicz; Iribarren; Sinisterra Tetrahedron Letters, 2003 , vol. 44, # 12 p. 2605 - 2609]
Chemoenzymatic preparation of nucleosides from furanoses
[Taverna-Porro, Marisa; Bouvier, Leon A.; Pereira, Claudio A.; Montserrat, Javier M.; Iribarren, Adolfo M. Tetrahedron Letters, 2008 , vol. 49, # 16 p. 2642 - 2645]
[Bookser, Brett C.; Raffaele, Nicholas B. Journal of Organic Chemistry, 2007 , vol. 72, # 1 p. 173 - 179]
[Gabrielsen, Bjarne; Phelan, Michael J.; Barthel-Rosa, Luis; See, Cathy; Huggins, John W.; et al. Journal of Medicinal Chemistry, 1992 , vol. 35, # 17 p. 3231 - 3238]